Compare NetEase Inc (NTES) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Novavax Inc — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while Novavax Inc trades at $8.08 (market cap $1.30B). The key difference: NetEase Inc is far larger — about 66.3× Novavax Inc's market cap, and NetEase Inc pays a 2.25% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NTES | NVAX | |
|---|---|---|
Market Cap | $86.14B | $1.30B |
Sector | Media | Health |
52-Week High | $159.34 | $11.19 |
52-Week Low | $109.26 | $6.22 |
Enterprise Value | $62.61B | $800.50M |
Dividend Yield | 2.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
